World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
73
Citations
19183
World Ranking
5932
National Ranking
2807

Research.com Recognitions

  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Martin Hoenigl is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with specific expertise in infectious diseases. They have contributed extensively to the study of fungal infections and antifungal resistance.

The scientist's publication record includes work on a variety of topics related to fungal infections, mycology, and respiratory diseases. Key topics in their research include:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Plant pathogens and fungal diseases
  • Infectious diseases and mycology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Interstitial lung diseases and idiopathic pulmonary fibrosis
  • HIV/AIDS research and interventions

Recent papers authored or co-authored by Martin Hoenigl cover issues related to COVID-19-associated fungal infections and antifungal treatments. Notable papers include:

  • "Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance," 2020, The Lancet Infectious Diseases
  • "COVID-19-associated fungal infections," 2022, Nature Microbiology
  • "COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment," 2020, Journal of Fungi
  • "The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin," 2021, Drugs
  • "Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology," 2021, The Lancet Infectious Diseases

Martin Hoenigl frequently publishes in several scientific journals, reflecting a broad engagement with mycology and infectious disease research. The main publication venues include:

  • Open Forum Infectious Diseases
  • Journal of Fungi
  • Mycoses
  • Mycopathologia
  • Clinical Microbiology and Infection

The scientist has collaborated with several recurrent coauthors, indicating ongoing research partnerships. Frequent collaborators include Oliver A. Cornely, Jon Salmanton-García, Jean-Pierre Gangneux, Juergen Prattes, and Philipp Koehler.

In addition to journal articles, Martin Hoenigl has contributed to book publications, including a work published by Springer International Publishing titled Infection Management in Hematology (2020).

Among their professional recognitions, Martin Hoenigl is a Fellow of the European Confederation of Medical Mycology (ECMM), underscoring their involvement in this specialized field.

Best Publications

  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Oliver A. Cornely;Ana Alastruey-Izquierdo;Dorothee Arenz;Sharon C. A. Chen

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.

    Martin Hoenigl;Martin Hoenigl;Rosanne Sprute;Matthias Egger;Amir Arastehfar

  • COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

    Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  • Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

    Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

    Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  • Performance of Galactomannan, Beta-d-Glucan, Aspergillus Lateral-Flow Device, Conventional Culture, and PCR Tests with Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis

    M. Hoenigl;J. Prattes;B. Spiess;J. Wagner

  • Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.

    Amir Arastehfar;Toni Gabaldón;Toni Gabaldón;Rocio Garcia-Rubio;Jeffrey D Jenks

  • COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?

    Amir Arastehfar;Agostinho Carvalho;M. Hong Nguyen;Mohammad Taghi Hedayati

  • Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

    Juergen Prattes;Joost Wauters;Daniele Roberto Giacobbe;Jon Salmanton-García

  • Improvement in the outcome of invasive fusariosis in the last decade

    M. Nucci;K. A. Marr;M. J G T Vehreschild;C. A. de Souza

  • Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia

    Helmut J F Salzer;Guido Schäfer;Martin Hoenigl;Martin Hoenigl;Gunar Günther

  • Diagnosing COVID-19-associated pulmonary aspergillosis.

    Paul E. Verweij;Jean Pierre Gangneux;Matteo Bassetti;Roger J.M. Brüggemann

  • Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men.

    Martin Hoenigl;Antoine Chaillon;David J. Moore;Sheldon R. Morris

  • Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.

    Oliver A. Cornely;Martin Hoenigl;Martin Hoenigl;Cornelia Lass‐Flörl;Sharon C. ‐A. Chen

  • Contaminated Handwashing Sinks as the Source of a Clonal Outbreak of KPC-2-Producing Klebsiella oxytoca on a Hematology Ward

    Eva Leitner;Gernot Zarfel;Josefa Luxner;Kathrin Herzog

  • Novel Tests for Diagnosis of Invasive Aspergillosis in Patients with Underlying Respiratory Diseases

    Juergen Prattes;Holger Flick;Florian Prüller;Christoph Koidl

  • Breakthrough invasive fungal infections: Who is at risk?

    Jeffrey D. Jenks;Oliver A. Cornely;Sharon C.A. Chen;George R. Thompson

  • Treatment of Aspergillosis.

    Jeffrey D Jenks;Martin Hoenigl

  • Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings

    David W Denning;Iain D Page;Jeremiah Chakaya;Kauser Jabeen

Frequent Co-Authors

Robert Krause
Robert Krause Medical University of Graz
Oliver A. Cornely
Oliver A. Cornely University of Cologne
Susan J. Little
Susan J. Little University of California, San Diego
Philipp Koehler
Philipp Koehler Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases
Davey M. Smith
Davey M. Smith University of California, San Diego
Sara Gianella
Sara Gianella University of California, San Diego
Sharon C.-A. Chen
Sharon C.-A. Chen Westmead Hospital
Ana Alastruey-Izquierdo
Ana Alastruey-Izquierdo Instituto de Salud Carlos III
Livio Pagano
Livio Pagano Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry in the USA opens doors to diverse career pathways, especially in health information and medical coding fields. Students interested in the intersection of science and healthcare technology often consider a health information management degree. These online programs are highly affordable and lead to in-demand roles managing patient data and health informatics.

A popular career choice is becoming a certified professional coder, which allows you to work with medical billing and coding for hospitals and clinics. The distinctions between various coding certifications like CPC and CCS can impact your role, salary, and day-to-day tasks. If you’re curious about earnings, learn more about medical coding salary prospects, which continue to grow with the healthcare industry's expansion.

Medical coding offers strong job security, remote work options, and clear pathways for advancement. However, it’s important to weigh all sides; check out the medical coding job outlook to understand both the benefits and challenges of this rewarding career path.

Best Scientists Citing Martin Hoenigl

Trending Scientists

Recently Published Articles